Comments
Loading...
IGC Pharma Analyst Ratings and Price Targets | AMEX:IGC | Benzinga
IGC Pharma Inc has a consensus price target of $3.88 based on the ratings of 2 analysts. The high is $4.25 issued by Ascendiant Capital on February 24, 2025. The low is $3.5 issued by Alliance Global Partners on March 6, 2025. The 3 most-recent analyst ratings were released by Alliance Global Partners, Ascendiant Capital, and Ascendiant Capital on March 6, 2025, February 24, 2025, and December 5, 2024, respectively. With an average price target of $3.92 between Alliance Global Partners, Ascendiant Capital, and Ascendiant Capital, there's an implied 1274.27% upside for IGC Pharma Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Alliance Global Partners
Ascendiant Capital
1calculated from analyst ratings
Analyst Ratings for IGC Pharma
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/06/2025 | Buy Now | 1128.07% | Alliance Global Partners | James Molloy29% | $3.5 → $3.5 | Reiterates | Buy → Buy | Get Alert |
| 02/24/2025 | Buy Now | 1391.23% | Ascendiant Capital | Edward Woo47% | $4 → $4.25 | Maintains | Buy | Get Alert |
| 12/05/2024 | Buy Now | 1303.51% | Ascendiant Capital | Edward Woo47% | $3.75 → $4 | Maintains | Buy | Get Alert |
| 09/03/2024 | Buy Now | 1215.79% | Ascendiant Capital | Edward Woo47% | $3.5 → $3.75 | Maintains | Buy | Get Alert |
| 07/29/2024 | Buy Now | 1128.07% | Ascendiant Capital | Edward Woo47% | $3.25 → $3.5 | Maintains | Buy | Get Alert |
| 07/17/2024 | Buy Now | 1128.07% | Alliance Global Partners | James Molloy29% | → $3.5 | Initiates | → Buy | Get Alert |
| 06/21/2024 | Buy Now | 1040.35% | Ascendiant Capital | Edward Woo47% | $3.25 → $3.25 | Reiterates | Buy → Buy | Get Alert |
FAQ
What is the target price for IGC Pharma (IGC) stock?
The latest price target for IGC Pharma (AMEX:IGC) was reported by Alliance Global Partners on March 6, 2025. The analyst firm set a price target for $3.50 expecting IGC to rise to within 12 months (a possible 1128.07% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for IGC Pharma (IGC)?
The latest analyst rating for IGC Pharma (AMEX:IGC) was provided by Alliance Global Partners, and IGC Pharma reiterated their buy rating.
When was the last upgrade for IGC Pharma (IGC)?
There is no last upgrade for IGC Pharma
When was the last downgrade for IGC Pharma (IGC)?
There is no last downgrade for IGC Pharma.
When is the next analyst rating going to be posted or updated for IGC Pharma (IGC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IGC Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IGC Pharma was filed on March 6, 2025 so you should expect the next rating to be made available sometime around March 6, 2026.
Is the Analyst Rating IGC Pharma (IGC) correct?
While ratings are subjective and will change, the latest IGC Pharma (IGC) rating was a reiterated with a price target of $3.50 to $3.50. The current price IGC Pharma (IGC) is trading at is $0.28, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.